PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Genentech, South San Francisco, CA.\', \'Hoffmann-La Roche Ltd, Mississauga, ON, Canada.\', \'Roche Products Ltd, Welwyn Garden City, United Kingdom.\', \'F. Hoffmann-La Roche Ltd, Basel, Switzerland.\', \'Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.\', \'Department of Respiratory Medicine, Queen Elizabeth University Hospital, Glasgow, United Kingdom.\', \'Department of Infectious Diseases, Bellvitge University Hospital, Bellvitge Biomedical Research Institute, University of Barcelona and Spanish Network for Research in Infectious Diseases, Barcelona, Spain.\', \'Intensive Care Unit and Inserm CIC1435 and UMR1092, CHU Limoges, Limoges, France.\', \'Center of Research and Disruption of Infectious Diseases, Department of Infectious Diseases, Copenhagen University Hospital, Amager Hvidovre, Hvidovre, Denmark.\', \'Medical Oncology, Intermountain Medical Group, St George, UT.\', \'School of Medicine and Surgery, University of Milano-Bicocca and Infectious Diseases Unit Azienda Ospedaliera San Gerardo di Monza, Monza, Italy.\', \'Pulmonary Surgery, Amphia Ziekenhuis, Breda, The Netherlands.\', \'Division of Hospital Medicine, Stanford University School of Medicine, Stanford, CA.\', \'Department of Infectious Diseases, Zealand University Hospital, Roskilde, Denmark.\', \'Service de Réanimation, Institut de Cardiologie, Hopital de la Pitié Salpêtrière, Paris, France.\', \'Department of Medicine, Baylor College of Medicine, Houston, TX.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1097/CCM.0000000000005229
?:doi
?:hasPublicationType
?:journal
  • Critical care medicine
is ?:pmid of
?:pmid
?:pmid
  • 34612846
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.116
?:rankingScore_hIndex
  • 246
is ?:relation_isRelatedTo_publication of
?:title
  • Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34612846>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34612846>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all